The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
fosphenytoin sodium · Injection
4 marketed package NDCs · 2 active manufacturers
Most dispensed: 50 mg/mL · Injection, Solution · #10 vial, single-doses/carton / 10 ml in 1 vial, single-dose · 50 mg/mL · Injection, Solution · #25 vial, single-doses/carton / 2 ml in 1 vial, single-dose
Same drug class
Other molecules FDA puts in Anti-epileptic Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- valproate sodium· in shortage
- divalproex sodium d/r· 1 maker
- divalproex sodium er· 1 maker
- lamotirigine· 1 maker
- lamotrigine chewable dispersible· 1 maker
- lamotrigine extended release· 1 maker
- lamotrigine er· 2 makers
- methsuximide· 3 makers
- extended phenytoin sodium· 4 makers
- lamotrigine extended-release· 4 makers
- tiagabine hydrochloride· 6 makers
- ethosuximide· 13 makers
Common questions
- Is Fosphenytoin sodium in shortage right now?
- No. FDA does not currently list Fosphenytoin sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Fosphenytoin sodium?
- 12 companies have marketed Fosphenytoin sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.